Literature DB >> 30957230

Multimorbidity Frameworks Impact Prevalence and Relationships with Patient-Important Outcomes.

Lauren E Griffith1, Anne Gilsing1, Dee Mangin2, Christopher Patterson3, Edwin van den Heuvel4, Nazmul Sohel1, Philip St John5, Marjan van den Akker6,7, Parminder Raina1.   

Abstract

OBJECTIVES: To explore how different frameworks and categories of chronic conditions impact multimorbidity (defined as two or more chronic conditions) prevalence estimates and associations with patient-important functional outcomes.
DESIGN: Baseline data from a population-based cohort study.
SETTING: National sample of Canadians. PARTICIPANTS: A total of 51 338 community-living adults, aged 45 to 85 years. MAIN OUTCOME MEASURES: Chronic conditions from three commonly recognized frameworks were categorized as: (1) diseases, (2) risk factors, or (3) symptoms. Estimates of multimorbidity prevalence were compared among frameworks by age and sex. Separate weighted logistic regression models were used to explore the impact of the different frameworks and categories of chronic conditions on odds ratios (ORs) for multimorbidity for four patient-important functional outcomes: disability, social participation restriction, and self-rated physical and mental health.
RESULTS: One framework included diseases and risk factors, and two frameworks included diseases, risk factors, and symptoms. The prevalence of multimorbidity differed among the frameworks, ranging from 33.5% to 60.6% having two or more chronic conditions. Including risk factors in frameworks increased prevalence estimates, while including symptoms increased prevalence estimates and associations with most patient-important outcomes. The two frameworks that included symptoms had the largest ORs for associations with disability, social participation restriction, and self-rated physical health but not self-rated mental health. Similar results were found when we compared ORs for patient-important outcome for multimorbidity based on three subframeworks: one including diseases only, one including diseases and risk factors, and one including diseases, risk factors, and symptoms.
CONCLUSIONS: Including risk factors appeared to increase only the prevalence of multimorbidity without significantly altering relationships to outcomes. The inclusion of symptoms increased prevalence and associations with patient-important outcomes. These findings underscore the importance of considering not only the number, but also the category, of conditions included in multimorbidity frameworks, as simply counting the number of diagnoses may reduce sensitivity to outcomes that are important to individuals. J Am Geriatr Soc 67:1632-1640, 2019.
© 2019 The American Geriatrics Society.

Entities:  

Keywords:  Canadian Longitudinal Study on Aging; aging; functional disability; multimorbidity; self-rated health; social participation

Mesh:

Year:  2019        PMID: 30957230     DOI: 10.1111/jgs.15921

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  15 in total

1.  Multimorbidity in Canadians living in the community: Results from the Canadian Longitudinal Study of Aging.

Authors:  Philip D St John; Verena Menec; Suzanne L Tyas; Robert Tate; Lauren Griffith
Journal:  Can Fam Physician       Date:  2021-03-16       Impact factor: 3.275

Review 2.  Multimorbidity.

Authors:  Søren T Skou; Frances S Mair; Martin Fortin; Bruce Guthrie; Bruno P Nunes; J Jaime Miranda; Cynthia M Boyd; Sanghamitra Pati; Sally Mtenga; Susan M Smith
Journal:  Nat Rev Dis Primers       Date:  2022-07-14       Impact factor: 65.038

3.  Prevalent Multimorbidity Combinations Among Middle-Aged and Older Adults Seen in Community Health Centers.

Authors:  Ana R Quiñones; Steele H Valenzuela; Nathalie Huguet; Maria Ukhanova; Miguel Marino; Jennifer A Lucas; Jean O'Malley; Teresa D Schmidt; Robert Voss; Katherine Peak; Nathaniel T Warren; John Heintzman
Journal:  J Gen Intern Med       Date:  2022-01-28       Impact factor: 6.473

4.  Functional limitations in people with multimorbidity and the association with mental health conditions: Baseline data from the Canadian Longitudinal Study on Aging (CLSA).

Authors:  Kathryn Fisher; Lauren E Griffith; Andrea Gruneir; David Kanters; Maureen Markle-Reid; Jenny Ploeg
Journal:  PLoS One       Date:  2021-08-11       Impact factor: 3.240

5.  The hidden complexity of measuring number of chronic conditions using administrative and self-report data: A short report.

Authors:  Lauren E Griffith; Andrea Gruneir; Kathryn A Fisher; Ross Upshur; Christopher Patterson; Richard Perez; Lindsay Favotto; Maureen Markle-Reid; Jenny Ploeg
Journal:  J Comorb       Date:  2020-06-26

6.  Patient-relevant outcomes: what are we talking about? A scoping review to improve conceptual clarity.

Authors:  Christine Kersting; Malte Kneer; Anne Barzel
Journal:  BMC Health Serv Res       Date:  2020-06-29       Impact factor: 2.655

7.  Individual and population level impact of chronic conditions on functional disability in older adults.

Authors:  Parminder Raina; Anne Gilsing; Alexandra J Mayhew; Nazmul Sohel; Edwin van den Heuvel; Lauren E Griffith
Journal:  PLoS One       Date:  2020-02-20       Impact factor: 3.240

8.  Comorbidity Patterns of Older Lung Cancer Patients in Northeast China: An Association Rules Analysis Based on Electronic Medical Records.

Authors:  Jia Feng; Xiao-Min Mu; Ling-Ling Ma; Wei Wang
Journal:  Int J Environ Res Public Health       Date:  2020-12-06       Impact factor: 3.390

9.  Patients' perspective on supposedly patient-relevant process and outcome parameters: a cross-sectional survey within the 'PRO patients study'.

Authors:  Christine Kersting; Julia Hülsmann; Klaus Weckbecker; Achim Mortsiefer
Journal:  BMC Health Serv Res       Date:  2022-01-14       Impact factor: 2.655

10.  Prevalence of multimorbid degenerative lumbar spinal stenosis with knee and/or hip osteoarthritis: protocol for a systematic review and meta-analysis.

Authors:  James J Young; Jan Hartvigsen; Rikke K Jensen; Ewa M Roos; Carlo Ammendolia; Carsten Bogh Juhl
Journal:  Syst Rev       Date:  2020-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.